Biofrontera Inc stock is traded at $0.8078, with a volume of 154,498. It is down -10.62% in the last 24 hours and down -13.33% over the past month. Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Previous Close:
$0.9038
Open:
$0.9055
24h Volume:
154,498
Relative Volume:
1.09
Market Cap:
$12.00M
Revenue:
$43.20M
Net Income/Loss:
-$11.09M
P/E Ratio:
-
EPS:
-$1.11
Net Cash Flow:
-$9.32M
1W Performance:
-7.46%
1M Performance:
-13.33%
6M Performance:
-29.14%
1Y Performance:
-30.36%
1-Day Range:
$0.00$0.00
1-Week Range:
$0.8001$0.9499
52-Week Range:
$0.5547$1.66
Biofrontera Inc Stock (BFRI) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS